Founder And Former Chief Investment Officer Of Infinity Q Pleads Guilty To Securities Fraud
FOR IMMEDIATE RELEASE
Founder And Former Chief Investment Officer Of Infinity Q Pleads Guilty To Securities Fraud
James Velissaris Inflated the Values of Numerous Positions in the Investment Funds Managed by Infinity Q and Falsified Documents to Infinity Q's Auditors and the
According to the allegations contained in the Indictment, other publicly available information, and statements made in court:
Background
VELISSARIS was the founder and chief investment officer of Infinity Q, an investment adviser that ran both a mutual fund (the "
A major component of both the
VELISSARIS' Scheme to Lie to Investors and Inflate Derivative Swap Positions
In fact, however, VELISSARIS defrauded Infinity Q's investors by taking an active role in the valuation of Infinity Q's positions and by modeling the positions in ways that were not based on the actual terms of the underlying contracts and were inconsistent with fair value. VELISSARIS' input into the BVAL valuation process was inconsistent with Infinity Q's representations about the independence of the process and allowed VELISSARIS to fraudulently mismark positions in BVAL. VELISSARIS engaged in the mismarking of positions in BVAL by making false entries in BVAL's system including by secretly altering the computer code employed by BVAL that caused BVAL to alter and disregard certain critical terms. Altering and disregarding terms in this fashion caused BVAL to report values that were artificially inflated and, often, much higher than fair value.
By manipulating OTC derivative positions in BVAL in this way, VELISSARIS caused numerous positions in the Investment Funds to have anomalous and, at times, impossible valuations. For example, at times, VELISSARIS made manipulations in either the
Ultimately, after VELISSARIS' mismarking scheme was uncovered in or about
VELISSARIS Lies to Auditors and Obstructs the
In order to hide this scheme and prevent its detection, VELISSARIS lied to numerous outside stakeholders and regulators. First, in order to prevent Infinity Q's outside auditor (the "Auditor") from discovering the fraud, VELISSARIS provided the Auditor with falsified term sheets from counterparties that he had altered to change the true terms of certain OTC derivative positions. In particular, in connection with a number of audits, the Auditor selected certain OTC positions that it would independently value in order to confirm the reasonableness of Infinity Q's values from BVAL. In order to ensure that the Auditor would not arrive at materially different results when independently valuing positions that VELISSARIS had manipulated in BVAL, VELISSARIS altered the terms of certain deal documents and provided them to the Auditor. After receiving these falsified documents and relying on them in its independent evaluation, the Auditor confirmed the reasonableness of VELISSARIS' valuations in BVAL.
Furthermore, beginning in
In
* * *
VELISSARIS, 38, of
The maximum potential sentence in this case is prescribed by
This case is being handled by the Office's
Contact:
Press Release Number:
22-359
Updated



A client accuses his insurance broker in Castellón of faking claims
Santa Clarita Man Sentenced to Nearly 61/2 Years in Prison for Stealing $1.7 Million from Investors via His Real Estate 'Coupon Bond' Scam
Advisor News
- How to discuss higher deductibles without losing client trust
- Take advantage of the exploding $800B IRA rollover market
- Study finds more households move investable assets across firms
- Could workplace benefits help solve America’s long-term care gap?
- The best way to use a tax refund? Create a holistic plan
More Advisor NewsAnnuity News
- Court fines Cutter Financial $100,000, requires client notice of guilty verdict
- KBRA Releases Research – Private Credit: From Acquisitions to Partnerships—Asset Managers’ Growing Role With Life/Annuity Insurers
- $80k surrender charge at stake as Navy vet, Ameritas do battle in court
- Sammons Institutional Group® Launches Summit LadderedSM
- Protective Expands Life & Annuity Distribution with Alfa Insurance
More Annuity NewsHealth/Employee Benefits News
- How to discuss higher deductibles without losing client trust
- HARNESSING THE TAF ANALYSIS REPORTING CHECKLIST TO ELEVATE TRANSPARENCY IN MEDICAID RESEARCH
- AHCCCS DIRECTOR VIRGINIA "GINNY" ROUNTREE RESIGNS FOR PERSONAL HEALTH CONCERNS
- Florida Blue expands cancer support for Medicare Advantage members
- Data from Stanford University Provide New Insights into Managed Care (The environmental chemical exposome and health insurance: Examining associations and effect modification of epigenetic aging in a representative sample of United States adults): Managed Care
More Health/Employee Benefits NewsLife Insurance News